Home Hybio Pharmaceutical Co., Ltd.

Hybio Pharmaceutical Co., Ltd.

Profile managed by Bizz Id

China 1998

Description

Hybio Pharmaceutical Co., Ltd. was founded in 1998 and is listed on the Shenzhen Stock Exchange under code 300199. It develops and manufactures peptide active ingredients and peptide finished products, and provides custom peptide synthesis, reference standards and CRO and CDMO services. Its headquarters and main peptide plant are in Nanshan, Shenzhen, with a finished dosage branch at Pingshan, an innovation base at Guanlan, and API, oral solid dosage and biopharmaceutical manufacturing in Wuhan. The company states that more than 15 of its products hold a DMF, a European ASMF or a written confirmation certificate, and that the Nanshan site has passed inspections by European, US, Korean and Chinese authorities.

Products

91 products

Abaloparatide

Musculoskeletal system and connective tissue diseases

USDMF (USA)

API (active ingredient) · CAS 247062-33-5

Verified on 2026-10-17

Abaloparatide: see suppliers →

AEEA-AEEA

Tech pack available

Intermediate · CAS 1143516-05-5

Verified on 2026-10-17

AEEA-AEEA: see suppliers →

Apraglutide

Digestive System Diseases

Under development

API (active ingredient) · CAS 1295353-98-8

Verified on 2026-10-17

Apraglutide: see suppliers →

Atosiban

Pregnancy, childbirth, and puerperium

ASMF / EDMF (EU) NMPA; WC

API (active ingredient) · CAS 90779-69-4

Verified on 2026-10-17

Atosiban: see suppliers →

Atosiban Acetate Injection

Obstetrics-and Gynecology

Tech pack available

Finished product (FDF)

Verified on 2026-10-17

Atosiban: see suppliers →

Biphenyl Diester Capsules

Digestive Tract and Metabolic System

Tech pack available

Finished product (FDF)

Verified on 2026-10-17

Biphenyl Diester: see suppliers →

Bivalirudin

Diseases of the circulatory system and diseases of the blood and hematopoietic organs

USDMF (USA)

API (active ingredient) · CAS 128270-60-0

Verified on 2026-10-17

Bivalirudin: see suppliers →

Boc-His(Trt)-Aib-Gln(Trt)-Gly-OH

Tech pack available

Intermediate

Verified on 2026-10-17

Boc-His(Trt)-Aib-Glu(OtBu)-Gly-OH

Tech pack available

Intermediate · CAS 1890228-73-5

Verified on 2026-10-17

Boc-His(Trt)-Ala-Glu(OtBu)-Gly-OH

Tech pack available

Intermediate · CAS 1418291-58-3

Verified on 2026-10-17

Boc-Tyr(tBu)-Aib-OH

Tech pack available

Intermediate · CAS 2639221-78-4

Verified on 2026-10-17

Bulevirtide

Mental and behavioral disorders

Under development

API (active ingredient) · CAS 2012558-47-1

Verified on 2026-10-17

Bulevirtide: see suppliers →

Cagrilintide

Endocrine, nutritional and metabolic diseases

Under development

API (active ingredient) · CAS 1415456-99-3

Verified on 2026-10-17

Cagrilintide: see suppliers →

Calcitonin (salmon)

Musculoskeletal system and connective tissue diseases

NMPA

Filing submitted

API (active ingredient) · CAS 9007-12-9

Verified on 2026-10-17

Calcitonin: see suppliers →

Cannabidiol

Nervous System Diseases

USDMF (USA)

API (active ingredient) · CAS 13956-29-1

Verified on 2026-10-17

Cannabidiol: see suppliers →

Carbetocin

Pregnancy, childbirth, and puerperium

ASMF / EDMF (EU) NMPA; WC

API (active ingredient) · CAS 37025-55-1

Verified on 2026-10-17

Carbetocin: see suppliers →

Carbetocin Injection

Obstetrics-and Gynecology

Tech pack available

Finished product (FDF)

Verified on 2026-10-17

Carbetocin: see suppliers →

Cetrorelix

Pregnancy, childbirth, and puerperium

USDMF (USA) NMPA

API (active ingredient) · CAS 120287-85-6

Verified on 2026-10-17

Cetrorelix: see suppliers →

Degarelix

Neoplasms

USDMF (USA) NMPA

API (active ingredient) · CAS 214766-78-6

Verified on 2026-10-17

Degarelix: see suppliers →

Desmopressin

Endocrine, nutritional, and metabolic diseases

USDMF (USA) CEP (EDQM, Europe) KDMF (Korea) NMPA; WC

API (active ingredient) · CAS 16679-58-6

Verified on 2026-10-17

Desmopressin: see suppliers →

Desmopressin Injection

Hemostatic agent

Tech pack available

Finished product (FDF)

Verified on 2026-10-17

Desmopressin: see suppliers →

Difelikefalin

Diseases of the urogenital system

Validation Completed; DMF

Tech pack available

API (active ingredient) · CAS 1024828-77-0

Verified on 2026-10-17

Difelikefalin: see suppliers →

Disposable Injection Pen

Medical Devices

Tech pack available

Equipment or machinery

Verified on 2026-10-17

Donidalorsen

Diseases of blood and hematopoietic organs

Under development

API (active ingredient) · CAS 2304692-48-4

Verified on 2026-10-17

Donidalorsen: see suppliers →

Elamipretide

Tumor

Under development

API (active ingredient) · CAS 736992-21-5

Verified on 2026-10-17

Elamipretide: see suppliers →

Enlicitide Decanoate (MK-0616)

Endocrine, nutritional and metabolic diseases

Under development

API (active ingredient) · CAS 2407527-16-4

Verified on 2026-10-17

Enlicitide: see suppliers →

Eptifibatide

Diseases of the circulatory system

USDMF (USA) NMPA; WC

API (active ingredient) · CAS 188627-80-7

Verified on 2026-10-17

Eptifibatide: see suppliers →

Eptifibatide Injection

Cardiovascular

Tech pack available

Finished product (FDF)

Verified on 2026-10-17

Eptifibatide: see suppliers →

Etelcalcetide

Diseases of the urogenital system

DMF

Tech pack available

API (active ingredient) · CAS 1262780-97-1

Verified on 2026-10-17

Etelcalcetide: see suppliers →

Exenatide

Endocrine, nutritional, and metabolic diseases

NMPA

Filing submitted

API (active ingredient) · CAS 141758-74-9

Verified on 2026-10-17

Exenatide: see suppliers →

Ferric carboxymaltose

Diseases of the blood and hematopoietic organs

Under development

API (active ingredient) · CAS 53858-86-9

Verified on 2026-10-17

Ferric carboxymaltose: see suppliers →

Fitusiran

Diseases of blood and hematopoietic organs

Under development

API (active ingredient) · CAS 1499251-18-1

Verified on 2026-10-17

Fitusiran: see suppliers →

Fmoc-Gly-Gly-OH

Tech pack available

Intermediate · CAS 35897-09-5

Verified on 2026-10-17

Fmoc-His-Aib-OH

Tech pack available

Intermediate · CAS 1446013-07-5

Verified on 2026-10-17

Fmoc-Ile-Aib-OH

Tech pack available

Intermediate · CAS 2171139-20-9

Verified on 2026-10-17

Fmoc-Ile-αMeLeu-Leu-OH

Tech pack available

Intermediate

Verified on 2026-10-17

Fmoc-L-Lys[Eic(OtBu)-γ-Glu(OtBu)-AEEA-AEEA]-OH

Tech pack available

Intermediate · CAS 2915356-76-0

Verified on 2026-10-17

Fmoc-L-Lys[Eic(OtBu)-γ-Glu(OtBu)-AEEA]-OH

Tech pack available

Intermediate · CAS 2612237-97-3

Verified on 2026-10-17

Fmoc-L-Lys[Ste(OtBu)-γ-Glu-(OtBu)-AEEA-AEEA]-OH

Tech pack available

Intermediate · CAS 1662688-20-1

Verified on 2026-10-17

Fmoc-Lys(Pal-Glu-OtBu)-OH

Tech pack available

Intermediate

Verified on 2026-10-17

Fmoc-Thr(tBu)-Phe-OH

Tech pack available

Intermediate · CAS 1962160-86-6

Verified on 2026-10-17

Ganirelix

Pregnancy, childbirth, and puerperium

USDMF (USA) ASMF / EDMF (EU) TGA; NMPA; WC

API (active ingredient) · CAS 124904-93-4

Verified on 2026-10-17

Ganirelix: see suppliers →

Ganirelix Acetate Injection

Obstetrics-and Gynecology

Tech pack available

Finished product (FDF)

Verified on 2026-10-17

Ganirelix: see suppliers →

Givosiran

Endocrine, nutritional and metabolic diseases

Under development

API (active ingredient) · CAS 1639325-43-1

Verified on 2026-10-17

Givosiran: see suppliers →

Glatiramer

Nervous System Diseases

USDMF (USA)

API (active ingredient) · CAS 147245-92-9

Verified on 2026-10-17

Glatiramer: see suppliers →

Glatiramer Injection

Immune System Modulation

Tech pack available

Finished product (FDF)

Verified on 2026-10-17

Glatiramer: see suppliers →

Glepaglutide

Digestive System Diseases

Under development

API (active ingredient) · CAS 914009-86-2

Verified on 2026-10-17

Glepaglutide: see suppliers →

Glucagon

Endocrine, nutritional, and metabolic diseases

NMPA

Filing submitted

API (active ingredient) · CAS 9007-92-5

Verified on 2026-10-17

Glucagon: see suppliers →

Inclisiran

Endocrine, nutritional and metabolic diseases

Under development

API (active ingredient) · CAS 1639324-58-5

Verified on 2026-10-17

Inclisiran: see suppliers →

Lanreotide

Tumors, as well as endocrine, nutritional, and metabolic diseases

DMF

Tech pack available

API (active ingredient) · CAS 108736-35-2

Verified on 2026-10-17

Lanreotide: see suppliers →

Leuprorelin

Tumors and diseases of the urogenital system

CEP (EDQM, Europe)

API (active ingredient) · CAS 53714-56-0

Verified on 2026-10-17

Leuprorelin: see suppliers →

Linaclotide

Diseases of the digestive system

USDMF (USA) NMPA; WC

API (active ingredient) · CAS 851199-59-2

Verified on 2026-10-17

Linaclotide: see suppliers →

Liraglutide

Endocrine, nutritional, and metabolic diseases

USDMF (USA) TGA; NMPA; WC

API (active ingredient) · CAS 204656-20-2

Verified on 2026-10-17

Liraglutide: see suppliers →

Liraglutide Injection

Diabetes Mellitus

Tech pack available

Finished product (FDF)

Verified on 2026-10-17

Liraglutide: see suppliers →

Motixafortide

Endocrine, nutritional and metabolic diseases

Under development

API (active ingredient) · CAS 664334-36-5

Verified on 2026-10-17

Motixafortide: see suppliers →

Nesiritide

Diseases of the circulatory system

USDMF (USA)

API (active ingredient) · CAS 114471-18-0

Verified on 2026-10-17

Nesiritide: see suppliers →

Octreotide

Neoplasms and Endocrine, Nutritional and Metabolic Diseases

CEP (EDQM, Europe) NMPA; WC

API (active ingredient) · CAS 83150-76-9

Verified on 2026-10-17

Octreotide: see suppliers →

Orforglipron

Endocrine, nutritional and metabolic diseases

Under development

API (active ingredient) · CAS 2212020-52-3

Verified on 2026-10-17

Orforglipron: see suppliers →

Oxytocin

Pregnancy, childbirth, and puerperium

USDMF (USA) CEP (EDQM, Europe) NMPA; WC

API (active ingredient) · CAS 50-56-6

Verified on 2026-10-17

Oxytocin: see suppliers →

Oxytocin Injection

Obstetrics-and Gynecology

Tech pack available

Finished product (FDF)

Verified on 2026-10-17

Oxytocin: see suppliers →

Palopegteriparatide

Endocrine, nutritional, and metabolic diseases

Under development

API (active ingredient) · CAS 2222514-07-8

Verified on 2026-10-17

Palopegteriparatide: see suppliers →

Pegcetacoplan

Diseases of blood and hematopoietic organs

Under development

API (active ingredient) · CAS 2019171-69-6

Verified on 2026-10-17

Pegcetacoplan: see suppliers →

Plecanatide

Diseases of the digestive system

Validation Completed; DMF

Tech pack available

API (active ingredient) · CAS 467426-54-6

Verified on 2026-10-17

Plecanatide: see suppliers →

Plozasiran

Endocrine, nutritional and metabolic diseases

Under development

API (active ingredient) · CAS 2379776-40-4

Verified on 2026-10-17

Plozasiran: see suppliers →

Protirelin

Factors affecting health status

NMPA

Filing submitted

API (active ingredient) · CAS 24305-27-9

Verified on 2026-10-17

Protirelin: see suppliers →

Retatrutide

Endocrine, nutritional, and metabolic diseases

Under development

API (active ingredient) · CAS 2381089-83-2

Verified on 2026-10-17

Retatrutide: see suppliers →

Rusfertide

Diseases of blood and hematopoietic organs

Under development

API (active ingredient) · CAS 1628323-80-7

Verified on 2026-10-17

Rusfertide: see suppliers →

Semaglutide (Chemical synthesis)

Endocrine, nutritional, and metabolic diseases

USDMF (USA) WC

API (active ingredient) · CAS 910463-68-2

Verified on 2026-10-17

Semaglutide: see suppliers →

Semaglutide (Semi-Recombinant)

Endocrine, nutritional, and metabolic diseases

USDMF (USA) WC

API (active ingredient) · CAS 910463-68-2

Verified on 2026-10-17

Semaglutide: see suppliers →

Semaglutide Injection

Diabetes Mellitus

Tech pack available

Finished product (FDF)

Verified on 2026-10-17

Semaglutide: see suppliers →

Sermelanotide

Endocrine, nutritional, and metabolic diseases

Under development

API (active ingredient) · CAS 920014-72-8

Verified on 2026-10-17

Sermelanotide: see suppliers →

Sitagliptin and Metformin Hydrochloride Tablets (II)

Diabetes Mellitus

Tech pack available

Finished product (FDF)

Verified on 2026-10-17

Sitagliptin: see suppliers → · Metformin: see suppliers →

Somatostatin

Digestive System Diseases

CEP (EDQM, Europe) NMPA; WC

API (active ingredient) · CAS 51110-01-1

Verified on 2026-10-17

Somatostatin: see suppliers →

Somatostatin for Injection

Digestive Tract and Metabolic System

Tech pack available

Finished product (FDF)

Verified on 2026-10-17

Somatostatin: see suppliers →

Ste-γ-Glu-AEEA-AEEA-OSU

Tech pack available

Intermediate · CAS 1169630-40-3

Verified on 2026-10-17

Survodutide

Diseases of the circulatory system

Under development

API (active ingredient) · CAS 2805997-46-8

Verified on 2026-10-17

Survodutide: see suppliers →

Teriparatide

Musculoskeletal system and connective tissue diseases

USDMF (USA) NMPA

API (active ingredient) · CAS 99294-94-7

Verified on 2026-10-17

Teriparatide: see suppliers →

Teriparatide Injection

Osteoporosis

Tech pack available

Finished product (FDF)

Verified on 2026-10-17

Teriparatide: see suppliers →

Terlipressin

Diseases of the digestive system and diseases of the urogenital system

CEP (EDQM, Europe) NMPA; WC

API (active ingredient) · CAS 14636-12-5

Verified on 2026-10-17

Terlipressin: see suppliers →

Terlipressin for Injection

Digestive Tract and Metabolic System

Tech pack available

Finished product (FDF)

Verified on 2026-10-17

Terlipressin: see suppliers →

Thymalfasin

Certain infectious and parasitic diseases

NMPA

Filing submitted

API (active ingredient) · CAS 69521-94-4

Verified on 2026-10-17

Thymalfasin: see suppliers →

Thymalfasin for Injection

Immune System Modulation

Tech pack available

Finished product (FDF)

Verified on 2026-10-17

Thymalfasin: see suppliers →

Thymopentin

Certain infectious and parasitic diseases, as well as factors affecting health status

NMPA

Filing submitted

API (active ingredient) · CAS 69558-55-0

Verified on 2026-10-17

Thymopentin: see suppliers →

Thymopentin for Injection

Immune System Modulation

Tech pack available

Finished product (FDF)

Verified on 2026-10-17

Thymopentin: see suppliers →

Tirzepatide

Endocrine, nutritional, and metabolic diseases

USDMF (USA) NMPA

API (active ingredient) · CAS 2023788-19-2

Verified on 2026-10-17

Tirzepatide: see suppliers →

Trimetazidine Tablets

Cardiovascular

Tech pack available

Finished product (FDF)

Verified on 2026-10-17

Trimetazidine: see suppliers →

Triptorelin

Neoplasms and Diseases of the Genitourinary System

NMPA

Filing submitted

API (active ingredient) · CAS 57773-63-4

Verified on 2026-10-17

Triptorelin: see suppliers →

Trofinetide

Diseases of the Nervous System

Under development

API (active ingredient) · CAS 853400-76-7

Verified on 2026-10-17

Trofinetide: see suppliers →

Vasopressin

Endocrine, nutritional, and metabolic diseases, as well as symptoms and signs

Under development

API (active ingredient) · CAS 11000-17-2

Verified on 2026-10-17

Vasopressin: see suppliers →

Ziconotide

Diseases of the Nervous System

Under development

API (active ingredient) · CAS 107452-89-1

Verified on 2026-10-17

Ziconotide: see suppliers →

Zilebesiran

Diseases of the circulatory system

Under development

API (active ingredient) · CAS 2380166-33-4

Verified on 2026-10-17

Zilebesiran: see suppliers →

Certifications

US FDA EU GMP MFDS NMPA ANVISA

Contact company

Other locations

Hybio Innovation Industrial Park (Shenzhen Longhua HQ & R&D centre)
No. 7 Guansheng 4th Road, Longhua District, Shenzhen (China)

Shenzhen Pingshan Branch - injectable FDF production base
No. 2 Luhui Road, National Bio-industry Base, Pingshan District, Shenzhen (China)

Hybio Pharmaceutical (Wuhan) Co., Ltd. - peptide & oligonucleotide API base
No. 9 Linkong West Street, Hybio Biopharmaceutical Park, Huangpi District, Wuhan (China)